Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases

Matrix Biology

Volumn 65, Issue , 2018, Pages 30-44

  Panwar, Preety ^a   Butler, Georgina S ^a   Jamroz, Andrew ^a   Azizi, Pouya ^a   Overall, Christopher M ^a   Brömme, Dieter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Advanced glycation products; Cathepsins; Collagen; Matrix metalloproteinases; Mineralization; Proteolysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CATHEPSIN K; CATHEPSIN V; COLLAGEN; COLLAGENASE 3; CYSTEINE DEPENDENT COLLAGENASE; FIBRILLAR COLLAGEN; GLYCOSAMINOGLYCAN; HYDROXYPROLINE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; UNCLASSIFIED DRUG; CTSK PROTEIN, MOUSE;

AGING; ARTICLE; COLLAGEN DEGRADATION; COLLAGEN FIBER; COLLAGEN FIBRIL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME STABILITY; HYDROLYSIS; MINERALIZATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; METABOLISM; PROTEIN DEGRADATION; PROTEIN STABILITY;

AGING; ANIMALS; CATHEPSIN K; COLLAGEN; GLYCATION END PRODUCTS, ADVANCED; GLYCOSAMINOGLYCANS; MATRIX METALLOPROTEINASES; MICE; PROTEIN STABILITY; PROTEOLYSIS;

EID: 85021214429     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2017.06.004     Document Type: Article

References (59)

1. Bonnans, C., Chou, J., Werb, Z., Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15:12 (2014), 786–801.
2. Tam, E.M., Wu, Y.I., Butler, G.S., Stack, M.S., Overall, C.M., Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage. J. Biol. Chem. 277:41 (2002), 39005–39014.
3. Chung, L., Dinakarpandian, D., Yoshida, N., Lauer-Fields, J.L., Fields, G.B., Visse, R., Nagase, H., Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J. 23:15 (2004), 3020–3030.
4. Pelman, G.R., Morrison, C.J., Overall, C.M., Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond. J. Biol. Chem. 280:3 (2005), 2370–2377.
5. Tam, E.M., Moore, T.R., Butler, G.S., Overall, C.M., Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J. Biol. Chem. 279:41 (2004), 43336–43344.
6. Toth, M., Sohail, A., Fridman, R., Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol. Biol. 878 (2012), 121–135.
7. Vu, T.H., Werb, Z., Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:17 (2000), 2123–2133.
8. Rohani, M.G., Parks, W.C., Matrix remodeling by MMPs during wound repair. Matrix Biol. 44–46 (2015), 113–121.
9. Adiguzel, E., Ahmad, P.J., Franco, C., Bendeck, M.P., Collagens in the progression and complications of atherosclerosis. Vasc. Med. 14:1 (2009), 73–89.
10. Higa, R., Kurtz, M., Capobianco, E., Martinez, N., White, V., Jawerbaum, A., Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis. Reprod. Toxicol. 32:4 (2011), 449–462.
11. Nabeshima, K., Inoue, T., Shimao, Y., Sameshima, T., Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 52:4 (2002), 255–264.
12. Karsenty, G., Park, R.W., Regulation of type I collagen genes expression. Int. Rev. Immunol. 12:2–4 (1995), 177–185.
13. Cox, T.R., Erler, J.T., Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Model. Mech. 4:2 (2011), 165–178.
14. Lu, P., Takai, K., Weaver, V.M., Werb, Z., Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol., 3(12), 2011.
15. Wood, L.K., Kayupov, E., Gumucio, J.P., Mendias, C.L., Claflin, D.R., Brooks, S.V., Intrinsic stiffness of extracellular matrix increases with age in skeletal muscles of mice. J. Appl. Physiol. 117:4 (2014), 363–369.
16. DeGroot, J., Verzijl, N., Wenting-Van Wijk, M.J., Bank, R.A., Lafeber, F.P., Bijlsma, J.W., TeKoppele, J.M., Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum. 44:11 (2001), 2562–2571.
17. Goldin, A., Beckman, J.A., Schmidt, A.M., Creager, M.A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:6 (2006), 597–605.
18. Johnson, R.C., Leopold, J.A., Loscalzo, J., Vascular calcification: pathobiological mechanisms and clinical implications. Circ. Res. 99:10 (2006), 1044–1059.
19. Hutson, H.N., Marohl, T., Anderson, M., Eliceiri, K., Campagnola, P., Masters, K.S., Calcific aortic valve disease is associated with layer-specific alterations in collagen architecture. PLoS One, 11(9), 2016, e0163858.
20. Bishop, P.N., Holmes, D.F., Kadler, K.E., McLeod, D., Bos, K.J., Age-related changes on the surface of vitreous collagen fibrils. Invest. Ophthalmol. Vis. Sci. 45:4 (2004), 1041–1046.
21. Scott, J.E., Proteoglycan-fibrillar collagen interactions. Biochem. J. 252:2 (1988), 313–323.
22. Li, Y., Liu, Y., Xia, W., Lei, D., Voorhees, J.J., Fisher, G.J., Age-dependent alterations of decorin glycosaminoglycans in human skin. Sci. Rep., 3, 2013, 2422.
23. Lee, D.H., Oh, J.H., Chung, J.H., Glycosaminoglycan and proteoglycan in skin aging. J. Dermatol. Sci. 83:3 (2016), 174–181.
24. Panwar, P., Lamour, G., Mackenzie, N.C., Yang, H., Ko, F., Li, H., Bromme, D., Changes in structural-mechanical properties and degradability of collagen during aging-associated modifications. J. Biol. Chem. 290:38 (2015), 23291–23306.
25. Verzijl, N., DeGroot, J., Thorpe, S.R., Bank, R.A., Shaw, J.N., Lyons, T.J., Bijlsma, J.W., Lafeber, F.P., Baynes, J.W., TeKoppele, J.M., Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 275:50 (2000), 39027–39031.
26. Sivan, S.S., Wachtel, E., Tsitron, E., Sakkee, N., van der Ham, F., Degroot, J., Roberts, S., Maroudas, A., Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid. J. Biol. Chem. 283:14 (2008), 8796–8801.
27. Gautieri, A., Vesentini, S., Redaelli, A., Buehler, M.J., Hierarchical structure and nanomechanics of collagen microfibrils from the atomistic scale up. Nano Lett. 11:2 (2011), 757–766.
28. Willett, T.L., Labow, R.S., Aldous, I.G., Avery, N.C., Lee, J.M., Changes in collagen with aging maintain molecular stability after overload: evidence from an in vitro tendon model. J. Biomech. Eng., 132(3), 2010, 031002.
29. Snedeker, J.G., Gautieri, A., The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly. Muscles Ligaments Tendons J. 4:3 (2014), 303–308.
30. Li, Q., Jiang, Q., Uitto, J., Ectopic mineralization disorders of the extracellular matrix of connective tissue: molecular genetics and pathomechanisms of aberrant calcification. Matrix Biol. 33 (2014), 23–28.
31. Stirban, A., Gawlowski, T., Roden, M., Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol. Metab. 3:2 (2014), 94–108.
32. Gautieri, A., Redaelli, A., Buehler, M.J., Vesentini, S., Age- and diabetes-related nonenzymatic crosslinks in collagen fibrils: candidate amino acids involved in advanced glycation end-products. Matrix Biol. 34 (2014), 89–95.
33. Panwar, P., Du, X., Sharma, V., Lamour, G., Castro, M., Li, H., Bromme, D., Effects of cysteine proteases on the structural and mechanical properties of collagen fibers. J. Biol. Chem. 288:8 (2013), 5940–5950.
34. Bromme, D., Lecaille, F., Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opin. Investig. Drugs 18:5 (2009), 585–600.
35. Lutgens, S.P., Cleutjens, K.B., Daemen, M.J., Heeneman, S., Cathepsin cysteine proteases in cardiovascular disease. FASEB J. 21:12 (2007), 3029–3041.
36. Podgorski, I., Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?. Future Med. Chem. 1:1 (2009), 21–34.
37. Buhling, F., Rocken, C., Brasch, F., Hartig, R., Yasuda, Y., Saftig, P., Bromme, D., Welte, T., Pivotal role of cathepsin K in lung fibrosis. Am. J. Pathol. 164:6 (2004), 2203–2216.
38. Zhang, D., Leung, N., Weber, E., Saftig, P., Bromme, D., The effect of cathepsin K deficiency on airway development and TGF-beta1 degradation. Respir. Res., 12, 2011, 72.
39. Samokhin, A.O., Wong, A., Saftig, P., Bromme, D., Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice. Atherosclerosis 200:1 (2008), 58–68.
40. Lutgens, E., Lutgens, S.P., Faber, B.C., Heeneman, S., Gijbels, M.M., de Winther, M.P., Frederik, P., van der Made, I., Daugherty, A., Sijbers, A.M., Fisher, A., Long, C.J., Saftig, P., Black, D., Daemen, M.J., Cleutjens, K.B., Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113:1 (2006), 98–107.
41. Sangiorgi, G., Rumberger, J.A., Severson, A., Edwards, W.D., Gregoire, J., Fitzpatrick, L.A., Schwartz, R.S., Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J. Am. Coll. Cardiol. 31:1 (1998), 126–133.
42. Schmidt, C., Fagerberg, B., Wikstrand, J., Hulthe, J., R.I.S.S. Group, Multiple risk factor intervention reduces cardiovascular risk in hypertensive patients with echolucent plaques in the carotid artery. J. Intern. Med. 253:4 (2003), 430–438.
43. Nandalur, K.R., Hardie, A.D., Raghavan, P., Schipper, M.J., Baskurt, E., Kramer, C.M., Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke 38:3 (2007), 935–940.
44. Wong, K.K., Thavornpattanapong, P., Cheung, S.C., Sun, Z., Tu, J., Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model. BMC Cardiovasc. Disord., 12, 2012, 7.
45. Aguda, A.H., Panwar, P., Du, X., Nguyen, N.T., Brayer, G.D., Bromme, D., Structural basis of collagen fiber degradation by cathepsin K. Proc. Natl. Acad. Sci. U. S. A. 111:49 (2014), 17474–17479.
46. Li, Z., Hou, W.S., Escalante-Torres, C.R., Gelb, B.D., Bromme, D., Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J. Biol. Chem. 277:32 (2002), 28669–28676.
47. Li, Z., Yasuda, Y., Li, W., Bogyo, M., Katz, N., Gordon, R.E., Fields, G.B., Bromme, D., Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J. Biol. Chem. 279:7 (2004), 5470–5479.
48. Manka, S.W., Carafoli, F., Visse, R., Bihan, D., Raynal, N., Farndale, R.W., Murphy, G., Enghild, J.J., Hohenester, E., Nagase, H., Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1. Proc. Natl. Acad. Sci. U. S. A. 109:31 (2012), 12461–12466.
49. Roughley, P.J., Barrett, A.J., The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis. Biochem. J. 167:3 (1977), 629–637.
50. Roberts, C.R., Mort, J.S., Roughley, P.J., Degradation of the proteoglycans of human articular cartilage by reactive oxygen metabolites. Basic Life Sci. 49 (1988), 353–356.
51. Cechowska-Pasko, M., Palka, J., Age-dependent changes in glycosaminoglycan content in the skin of fasted rats. A possible mechanism. Exp. Toxicol. Pathol. 52:2 (2000), 127–131.
52. Nakayama, Y., Narita, T., Mori, A., Uesaka, S., Miyazaki, K., Ito, H., The effects of age and sex on chondroitin sulfates in normal synovial fluid. Arthritis Rheum. 46:8 (2002), 2105–2108.
53. Roughley, P.J., White, R.J., Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J. Biol. Chem. 255:1 (1980), 217–224.
54. Glant, T.T., Buzas, E.I., Finnegan, A., Negroiu, G., Cs-Szabo, G., Mikecz, K., Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J. Immunol. 160:8 (1998), 3812–3819.
55. Overal, C.M., Sodek, J., Initial characterization of a neutral metallo-endoproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts and identified in gingival crevicular fluid. J. Dent. Res. 66 (1987), 1271–1281.
56. Eckhard, U., Huesgen, P.F., Schilling, O., Bellac, C.L., Butler, G.S., Cox, J.H., Dufour, A., Goebeler, V., Kappelhoff, R., Auf dem Keller, U., Klein, T., Lange, P.F., Marino, G., Morrison, C.J., Prudova, A., Rodriguez, D., Starr, A.E., Wang, Y., Overall, C.M., Active site specificity profiling datasets of matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and 14. Data Brief 7 (2016), 299–310.
57. Linnevers, C.J., McGrath, M.E., Armstrong, R., Mistry, F.R., Barnes, M., Klaus, J.L., Palmer, J.T., Katz, B.A., Brömme, D., Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex. Protein Sci. 6 (1997), 919–921.
58. Brömme, D., Li, Z., Barnes, M., Mehler, E., Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry 38 (1999), 2377–2385.
59. Tan, E.P., Ng, S.Y., Lim, C.T., Tensile testing of a single ultrafine polymeric fiber. Biomaterials 26:13 (2005), 1453–1456.